4893 Noile-Immune Biotech Inc.ノイルイミューン・バイオテックTSE Growth / Pharmaceuticals
0 posts
Noile-Immune Biotech Inc. (4893) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
Noile-Immune Biotech Inc. (4893) Stock Price HistoryNear an all-time low
Noile-Immune Biotech Inc. closed at ¥75.0 on Nov 20, 2026, −16.7% over 1 month, −52.2% over 1 year.
If you had invested ¥100,000 1 month ago, it would be worth ¥83,333 today (−16.7%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −11.9%, while this stock moved −16.7%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥75.0 | −3 | −3.85% |
| Nov 19 (Thu) | ¥78.0 | +1 | +1.30% |
| Nov 18 (Wed) | ¥77.0 | −4 | −4.94% |
| Nov 17 (Tue) | ¥81.0 | +0 | +0.00% |
| Nov 16 (Mon) | ¥81.0 | −6 | −6.90% |
| Nov 13 (Fri) | ¥87.0 | +1 | +1.16% |
| Nov 12 (Thu) | ¥86.0 | +0 | +0.00% |
| Nov 10 (Tue) | ¥86.0 | +1 | +1.18% |
| Nov 9 (Mon) | ¥85.0 | +6 | +7.59% |
| Nov 6 (Fri) | ¥79.0 | −5 | −5.95% |
If you had invested ¥100,000 3 months ago, it would be worth ¥53,571 today (−46.4%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −14.8%, while this stock moved −46.4%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥75.0 | −3 | −3.85% |
| Nov 19 (Thu) | ¥78.0 | +1 | +1.30% |
| Nov 18 (Wed) | ¥77.0 | −4 | −4.94% |
| Nov 17 (Tue) | ¥81.0 | +0 | +0.00% |
| Nov 16 (Mon) | ¥81.0 | −6 | −6.90% |
| Nov 13 (Fri) | ¥87.0 | +1 | +1.16% |
| Nov 12 (Thu) | ¥86.0 | +0 | +0.00% |
| Nov 10 (Tue) | ¥86.0 | +1 | +1.18% |
| Nov 9 (Mon) | ¥85.0 | +6 | +7.59% |
| Nov 6 (Fri) | ¥79.0 | −5 | −5.95% |
If you had invested ¥100,000 6 months ago, it would be worth ¥58,594 today (−41.4%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −5.6%, while this stock moved −41.4%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥75.0 | −11.8% |
| Oct 2026 | ¥85.0 | −27.4% |
| Sep 2026 | ¥117 | −25.0% |
| Aug 2026 | ¥156 | +12.2% |
| Jul 2026 | ¥139 | +16.8% |
| Jun 2026 | ¥119 | −11.9% |
| May 2026 | ¥135 | −11.2% |
If you had invested ¥100,000 1 year ago, it would be worth ¥47,771 today (−52.2%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +13.3%, while this stock moved −52.2%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥75.0 | −11.8% |
| Oct 2026 | ¥85.0 | −27.4% |
| Sep 2026 | ¥117 | −25.0% |
| Aug 2026 | ¥156 | +12.2% |
| Jul 2026 | ¥139 | +16.8% |
| Jun 2026 | ¥119 | −11.9% |
| May 2026 | ¥135 | −11.2% |
| Apr 2026 | ¥152 | +5.6% |
| Mar 2026 | ¥144 | −12.7% |
| Feb 2026 | ¥165 | +11.5% |
| Jan 2026 | ¥148 | +11.3% |
| Dec 2025 | ¥133 | −17.9% |
| Nov 2025 | ¥162 | ― |
If you had invested ¥100,000 3 years ago, it would be worth ¥18,892 today (−81.1%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +67.8%, while this stock moved −81.1%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥75.0 | −43.6% |
| 2025 | ¥133 | ― |
If you had invested ¥100,000 5 years ago, it would be worth ¥12,500 today (−87.5%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +70.0%, while this stock moved −87.5%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥75.0 | −43.6% |
| 2025 | ¥133 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Jun 2023). Please check the latest prices before trading.
Noile-Immune Biotech Inc. (4893) financial indicators
PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.
Key features of Noile-Immune Biotech Inc. (4893)
Business overview
Guided by the principle of "contributing to a society that can overcome cancer," the company's main business is developing CAR-T cell therapies for solid tumors using its own technology. It applies PRIME technology, exclusively licensed from Yamaguchi University and its technology licensing organization Yamaguchi TLO, which is expected to deliver strong therapeutic effects by activating not only the administered CAR-T cells but also the immune cells in the patient's body. Its hybrid business model combines in-house drug discovery with joint pipelines in which it licenses PRIME technology to other companies. It operates a single cancer immunotherapy drug discovery segment.
Summarized from the annual securities report (fiscal year ended December 2025) filed on EDINET.
Position within Pharmaceuticals (79 companies)
| PBR | 0.96x | Below the sector median of 1.86x (No. 19 from the lowest) |
|---|---|---|
| Market cap | ¥3.3 bn | No. 68 in the sector (largest first) |
Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.
Price milestones
| 52-week high | ¥205 | 3/16 |
|---|---|---|
| 52-week low | ¥75 | 11/20 |
| Current position | 0.0% | Where the low is 0% and the high is 100% (close on 11/20: ¥75) |
| Year to date | -43.6% | No. 63 of 77 in the sector (best first) |
| 1 year | -52.2% |
Based on closing prices (adjusted for stock splits, excluding dividends).
Kabutaro's ranking history
| Top 50 losers | 3 times | Latest: 10/7 (No. 22) |
|---|
Gainers and losers have been recorded since 9/2026.
Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.
Recent disclosures (TDnet, in Japanese)
- 11/13 15:302026年12月期 第3四半期決算短信〔日本基準〕(非連結)
- 11/02 16:10行使価額修正条項付新株予約権の月間行使状況に関するお知らせ
- 10/21 16:40行使価額修正条項付新株予約権の大量行使に関するお知らせ
- 10/05 16:00第三者割当によるノイルイミューン・バイオテック株式会社第14回新株予約権 (行使価額修正条項付)の発行に係る払込完了に関するお知らせ
- 09/18 16:31新株予約権発行による資金調達に関する補足説明資料
- 09/18 16:30第三者割当によるノイルイミューン・バイオテック株式会社第14回新株予約権(行使価額修正条項付)の発行に関するお知らせ
Filings from the past 12 months (6).
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
No posts yet. Be the first to write something.
Write on the Noile-Immune Biotech Inc. board
More Japanese stocks in English
- Cuorips Inc.4894
- K Pharma,Inc.4896
- TSE REIT Logistics Focus ETF489A
- KONICA MINOLTA,INC.4902
- SENSE TRUST Co.,Ltd.490A
- Lion Corporation4912
- TAKASAGO INTERNATIONAL CORPORATION4914
- IVY COSMETICS CORPORATION4918
- Milbon Co.,Ltd.4919
- iShares S&P 500 Ex-Financials JPY Hedged ETF491A
- Nippon Shikizai,Inc.4920
- KOSE Holdings Corporation4922